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Purpose: Cancer stem cells have increased resistance against a variety of anti-tumor treatment modalities. Vasculogenic
mimicry (VM) patterns are present in numerous malignant tumor types, represent the formation of perfusion pathways
by tumor cells, and their presence in tumors is associated with adverse outcome. Earlier we have shown that VM-forming
tumor cells in three-dimensional (3D) uveal melanoma cultures have increased resistance against cytotoxic agents and
oncolytic herpes simplex virus-mediated destruction. The purpose of the current study was to explore the possibility that
this increased resistance of VM-forming tumor cells is due to a cancer stem cell phenotype.
Methods: The expression of cancer stem cell marker cluster of differentiation 271 (CD271) was determined in traditional
two-dimensional (2D) and 3D cultures of C918 uveal melanoma cells by fluorescent immunocytochemistry.
Results: We found that the VM-forming tumor cell subpopulation in 3D cultures expressed CD271. In contrast, cells
grown in 2D cultures and tumor cell subpopulations not participating in VM formation in 3D cultures were negative for
CD271.
Conclusions: These findings suggest that VM-forming uveal melanoma cells acquire a cancer stem cell-like phenotype
that may play a role in the increased therapy resistance of these cells.
According  to  the  cancer  stem  cell  hypothesis,  a
subpopulation of malignant cells capable of self-renewal is
responsible for tumor initiation, progression, and generation
of phenotypic heterogeneity. Importantly, cancer stem cells
also have increased resistance against a variety of anti-tumor
treatment modalities [1,2]. As cancer stem cells represent a
unique  subpopulation  of  tumor  cells,  isolation  and
characterization of these cells has critical importance for the
development of new therapeutic strategies [3].
One  of  the  most  studied  tumor  stem  cell-markers  is
cluster of differentiation 271 (CD271). CD271 (known as also
nerve  growth  factor  receptor,  NGFR  or  p75NTR)  is  a
neurotrophin receptor, which can bind all of the neurotrophins
by similar affinity [4]. It has contradictory actions; it functions
to promote cell survival or induce cell death [5]. Expression
of CD271 has been found in several human neural crest-
derived  tissues  and  in  some  human  cancers,  including
melanomas  [6].  Recently,  CD271  has  been  used  as  an
important cancer stem cell marker in melanoma [3,7,8].
Vasculogenic  mimicry  (VM)  patterns  are  present  in
numerous malignant tumor types, represent the formation of
perfusion  pathways  by  tumor  cells,  and  their  presence  in
tumors is associated with adverse outcome [9-16]. While VM
formation  is  clearly  a  marker  of  highly  invasive  tumor
phenotype,  mechanisms  by  which  these  structures  may
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contribute to adverse outcome are not well understood. It has
been  proposed  that  VM  formation  may  facilitate  tumor
perfusion and the physical connection between VM and blood
vessels may also facilitate hematogeneous dissemination of
tumor  cells  [14].  Recent  studies  suggest  that  malignant
melanoma initiating cells (MMIC) are specifically associated
with VM and it has been proposed that one mechanism by
which MMIC promote tumor growth is by the induction of
VM  formation  by  MMIC  [17].  Recent  studies  in  our
laboratory indicate that VM-forming tumor cells in three-
dimensional (3D) uveal melanoma cultures have increased
resistance  against  cytotoxic  agents  and  oncolytic  herpes
simplex  virus-mediated  destruction  [18,19].  These
observations raise the possibility that the increased therapy
resistance of VM-forming tumor cells is due to a cancer stem
cell phenotype. To explore this possibility, the current study
was designed to determine the expression of a known cancer
stem cell marker, CD271 in traditional two-dimensional (2D)
and 3D cultures of C918 uveal melanoma cells by fluorescent
immunocytochemistry. C918 uveal melanoma cells have been
reported to form VM in 3D cultures [18]. As controls, we also
studied CD271 expression in another uveal melanoma cell
line, OCM1 that does not form VM in culture [18]. We found
that the VM-forming tumor cell subpopulation in 3D C918
cultures  expressed  CD271.  In  contrast,  C918  cells  in  2D
cultures and tumor cell subpopulations not participating in
VM  formation  in  3D  cultures  were  negative  for  CD271.
Neither 2D nor 3D cultures of OCM1 uveal melanoma cells
expressed CD271. These findings suggest that a cancer stem
Molecular Vision 2012; 18:588-592 <http://www.molvis.org/molvis/v18/a64>
Received 26 January 2012 | Accepted 28 February 2012 | Published 2 March 2012
© 2012 Molecular Vision
588cell-like phenotype may play a role in the increased therapy
resistance of VM-forming tumor cells.
METHODS
Cells:  C918  and  OCM1  uveal  melanoma  cell  lines  were
maintained  in  Eagle's  Minimal  Essential  Medium
(BioWhittaker Inc., Walkersville, MD) supplemented with
heat inactivated 15% fetal bovine serum (Fisher, Ontario,
Canada) without the addition of exogenous ECM molecules
or growth factors. These cell lines have been described in
detail previously [20-23].
2D and 3D uveal melanoma cultures: Melanoma cells were
grown  on  eight-well  glass  chamber  slides  (Lab-Tek  II,
Naperville, IL) in Eagle’s Minimal Essential Medium medium
either in the presence (3D cultures) or in the absence (2D
cultures) of ECM rich in laminin (Matrigel, BD Biosciences,
Bedford, MA). For 3D cultures, Matrigel was poured onto
tissue  culture  plates  to  a  depth  of  approximately  0.2  mm
followed by polymerization for 1 h at 37 °C before placement
of melanoma cells on the Matrigel surface. Cultures were
incubated in repeatedly refreshed culture medium three-times
a week at 37 °C in a humidified atmosphere containing 5%
CO2.
Fluorescent immunocytochemistry: C918 and OCM1 uveal
melanoma cells cultured with or without Matrigel were fixed
in 2% formalin for 20 min in room temperature after forming
VM  structure  under  3D  culture  conditions  or  confluent
monolayer in 2D cultures. For CD271 labeling, cultures were
incubated with monoclonal anti-human rat p75 NGF receptor
as primary antibody (Abcam, Cambridge, MA) at 10 µg/ml
final  concentration  for  1h  at  room  temperature.  For
visualization of CD271 on uveal melanoma cells, cultures
were  incubated  with  FITC  conjugated  polyclonal  anti-rat
rabbit IgGs (Abcam) at 10 µg/ml final concentration for 1 h
at room temperature in dark. Green fluorescence was detected
by  under  an  inverted  fluorescent  microscope  (Leica,
Bannockburn, IL).
RESULTS
VM-forming C918 uveal melanoma cells express CD271 in
3D cultures: To detect CD271 expression in C918 and OCM1
cultures,  uveal  melanoma  cells  were  seeded  onto  plastic
culture  dishes  to  establish  2D  cultures  and  onto  Matrigel
matrix surface to form 3D structures (Figure 1). Both C918
and OCM1 cell cultures became confluent in the plastic dish
and formed monolayer. C918 melanoma cells cultured in the
presence  of  Matrigel  matrix  formed  a  variety  of
morphologically distinguishable tumor cell subpopulations
including VM (Figure 1A,B and Figure 2E,G). Specifically
and as described in detail previously (Valyi-Nagy et al. [18]),
these subpopulations included cells that grew in monolayer
on the Matrigel surface, cells that formed VM on the Matrigel
surface and tumor cells that grew as a monolayer on the
bottom of the culture dish under the Matrigel layer (Figure
1A,B and Figure 2E,G). OCM1 cells in 3D cultures formed
cell aggregates on the Matrigel surface and invaded Matrigel
without forming VM. Both 2D and 3D cultures were labeled
with  CD271  antibody,  then  FITC-conjugated  secondary
antibody.  For  control  cultures,  no  primary  antibody  was
added. We found that C918 uveal melanoma cells cultured
under 2D conditions did not express CD271 (Figure 2D). In
contrast,  a  subpopulation  of  C918  cells  cultured  in  3D,
specifically VM-forming cells expressed CD271 at clearly
detectable  level  (Figure  2H).  Interestingly,  other
subpopulations  of  uveal  melanoma  cells  in  3D  cultures,
including monolayer forming cells on the Matrigel surface
Figure 1. Morphology of 3D C918 uveal melanoma cultures. Pictures of a 3D C918 uveal melanoma culture with focus either on cells growing
on the Matrigel surface (A) or on cells growing on the bottom of the tissue culture well (B). Vasculogenic mimicry (VM) patterns are marked
by arrows, asterisks point to cells growing in monolayer on the Matrigel surface and arrowheads highlight cells growing on the bottom of the
culture dish. Magnification: 200×.
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589and on the bottom of the culture dish were CD271 negative
(Figure 2H). Neither 2D nor 3D cultures of OCM1 uveal
melanoma cells expressed CD271 (data not shown). Control
2D  and  3D  uveal  melanoma  cultures  exposed  only  to
secondary antibody remained CD271 negative (Figure 2B,F,
respectively).
DISCUSSION
Here we show for the first time that a morphologically distinct
subpopulation of uveal melanoma cells, VM-forming tumor
cells express CD271, a known cancer stem cell marker in 3D
cultures in the presence of laminin-rich ECM.
It is well known that tumor cells cultured in the presence
of  extracellular  matrix  components  or  on  non-adherent
surfaces form 3D structures. In these 3D cultures, tumor cells
are more resistant to chemotherapeutic drugs and radiation,
than in the traditionally used two-dimensional 2D cultures
[24-27]. Interestingly, 3D spheroid cultures of tumor cells
grown in stem cell media or in the presence of a hydrophobic
substrate,  polydimethylsiloxane  can  become  enriched  in
cancer stem cells [3,28].
Recently we found that uveal melanoma cells grown in
3D cultures are more resistant to oncolytic effect of herpes
simplex  virus  than  cells  grown  in  2D  cultures  [18,23].
Furthermore, we have shown that VM-forming tumor cells in
3D uveal melanoma cultures have increased resistance against
cytotoxic agents and oncolytic herpes simplex virus-mediated
destruction [18,19]. These observations raise the possibility
that there is a cause and effect connection between cancer stem
cell  enrichment  in  VM  and  increased  resistance  to
chemotherapeutic agents and virotherapy in 3D melanoma
cell cultures. To find the answer to this question, we aimed to
determine whether the VM subpopulation of C918 cells with
increased resistance to herpes simplex virus type 1 (HSV-1)
have cancer stem cell-like phenotype. As controls, we also
studied CD271 expression in another uveal melanoma cell
line, OCM1 that does not form VM in culture [18].
Recent published work suggests that tumor stem cells are
present in uveal melanoma [29,30]. In gene set enrichment
analysis of human uveal melanoma samples, a stem cell-like
phenotype was associated with metastasis [29]. In another
study, another stem cell marker CD133 was expressed by
some tumor cells in human uveal melanoma tissue indicating
that uveal melanoma may contain cancer stem cells [30].
We used CD271 as cancer stem cell marker in the current
work because the usefulness of CD271 as a melanoma cancer
stem cell marker is well documented by recent reports [7,8].
Specifically, a CD271+ cell population isolated directly from
aggressive melanoma samples and transplanted into T-, B-
and natural-killer cell deficient mice resulted in melanoma
formation at a markedly higher rate than CD271- cells [7].
Interestingly, most of CD271 expressing cells completely or
Figure 2. CD271 stem cell marker expression in C918 uveal melanoma cultures. The upper row of pictures demonstrates the morphology of
two-dimensional (2D; A and C) and three-dimensional (3D; E and G) cultures of C918 uveal melanoma with the formation of prominent VM
in 3D cultures. Arrows in E and G point to VM. Asterisks in E and G point to cells growing in monolayer on the Matrigel surface. Arrowheads
in E and G point to cells growing on the bottom of the culture dish. Panel H demonstrates detection of CD271 expression by VM-forming
tumor cells by immunofluorescence in 3D cultures. No CD271 expression was detected in 2D cultures (D). CD271 expression was also not
detected in control 2D and 3D cultures where no primary antibody was used (B and F). Magnification: 200×.
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590partially  lacked  the  expression  of  other  melanoma  tumor
antigens, such as tyrosinase and melanoma antigen recognized
by T cells (MART1) [7], indicating that CD271+ melanoma
cells have a less differentiated phenotype. Important features
of cancer stem cells include the ability to reproduce the full
heterogeneity of the parental tumor and continuous growth
even after multiple passages [8,31]. Using melanoma cell
isolation and xenotransplantation, Civenni et al. [8] proved
that  CD271-positive  melanoma  cells  meet  the  above
described definition of the cancer stem cells [8].
In our experiments, C918 uveal melanoma cells did not
express CD271 in traditional 2D cultures; however, in 3D
cultures, VM-forming C918 uveal melanoma cells expressed
CD271. OCM1 uveal melanoma cells did not form VM and
did not express CD271. These data suggest that VM-forming
C918 cells have a stem cell-like phenotype.
It is already known that VM-forming tumor cells from
aggressive  melanoma  display  increased  levels  of  genes
associated with undifferentiated embryonic-like phenotype
[16]. Recent studies also indicated that malignant melanoma
initiating cells (MMIC) are specifically associated with VM
and it has been proposed that one mechanism by which MMIC
promote tumor growth is by the induction of VM formation
by MMIC [17].
In summary, our results indicate that uveal melanoma
cells,  under  the  3D  culture  conditions  that  facilitate  the
generation of VM patterns, may express a phenotypic marker
– CD271 – that is associated with a stem-cell phenotype. This
observation is consistent with and extends previous reports
suggesting a connection between cancer stem cells and VM.
It is clear that our findings represent only initial observations
and an extension of our studies to human uveal melanoma
tissues as well as the use of additional stem cell-markers, such
as CD133, CD166 and nestin will be needed to fully explore
the association between VM-formation and cancer stem cell
phenotype. However, even at this stage, our results raise the
possibility that increased therapy-resistance of VM-forming
tumor cells is due to a cancer stem cell-like phenotype.
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